221 related articles for article (PubMed ID: 22361757)
1. Rationale of azithromycin prescribing practices for enteric fever in India.
Rai S; Jain S; Prasad KN; Ghoshal U; Dhole TN
Indian J Med Microbiol; 2012; 30(1):30-3. PubMed ID: 22361757
[TBL] [Abstract][Full Text] [Related]
2. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
[TBL] [Abstract][Full Text] [Related]
3. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
[TBL] [Abstract][Full Text] [Related]
4. [A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
Gaborieau V; Weill FX; Marchou B
Med Mal Infect; 2010 Dec; 40(12):691-5. PubMed ID: 20724089
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India.
Choudhary A; Gopalakrishnan R; Nambi PS; Ramasubramanian V; Ghafur KA; Thirunarayan MA
Indian J Med Res; 2013 Apr; 137(4):800-2. PubMed ID: 23703350
[TBL] [Abstract][Full Text] [Related]
6. Trends in antimicrobial susceptibility of Salmonella Typhi from North India (2001-2012).
Singhal L; Gupta PK; Kale P; Gautam V; Ray P
Indian J Med Microbiol; 2014; 32(2):149-52. PubMed ID: 24713900
[TBL] [Abstract][Full Text] [Related]
7. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
[TBL] [Abstract][Full Text] [Related]
8. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India.
Gupta V; Kaur J; Kaistha N
Trop Doct; 2009 Jan; 39(1):28-30. PubMed ID: 19211419
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.
Menezes GA; Harish BN; Khan MA; Goessens WH; Hays JP
Clin Microbiol Infect; 2012 Mar; 18(3):239-45. PubMed ID: 21714829
[TBL] [Abstract][Full Text] [Related]
10. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.
Sharma P; Dahiya S; Manral N; Kumari B; Kumar S; Pandey S; Sood S; Das BK; Kapil A
Indian J Med Microbiol; 2018; 36(1):70-76. PubMed ID: 29735830
[TBL] [Abstract][Full Text] [Related]
11. Trends in antibiotic susceptibility of enteric fever isolates in East London.
Dave J; Sefton A; de Pinna E; Woodford N; Meade R; Jordan M; Grant K; Holliman R; Millar M
Travel Med Infect Dis; 2015; 13(3):230-4. PubMed ID: 25964222
[TBL] [Abstract][Full Text] [Related]
12. Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry.
Madhulika U; Harish BN; Parija SC
Indian J Med Res; 2004 Aug; 120(2):111-4. PubMed ID: 15347861
[TBL] [Abstract][Full Text] [Related]
13. Absence of multidrug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolates with intermediate susceptibility to ciprofloxacin.
Misra R; Prasad KN; Amrin N; Kapoor P; Singh S; Ghar M
Trans R Soc Trop Med Hyg; 2015 Aug; 109(8):538-40. PubMed ID: 25979527
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi.
Kadhiravan T; Wig N; Kapil A; Kabra SK; Renuka K; Misra A
BMC Infect Dis; 2005 May; 5():37. PubMed ID: 15904505
[TBL] [Abstract][Full Text] [Related]
16. Low-level quinolone-resistance in multi-drug resistant typhoid.
Mirza SH; Khan MA
J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi.
Jain S; Das Chugh T
J Infect Dev Ctries; 2013 Nov; 7(11):788-95. PubMed ID: 24240035
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India.
Bandyopadhyay R; Balaji V; Yadav B; Jasmine S; Sathyendra S; Rupali P
Trop Doct; 2018 Jul; 48(3):182-188. PubMed ID: 29495943
[TBL] [Abstract][Full Text] [Related]
19. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia.
Kasper MR; Sokhal B; Blair PJ; Wierzba TF; Putnam SD
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):207-9. PubMed ID: 19800753
[TBL] [Abstract][Full Text] [Related]
20. High level of resistance to nalidixic acid in Salmonella enterica serovar Typhi in Central India.
Kumar Y; Sharma A; Mani KR
J Infect Dev Ctries; 2009 Jul; 3(6):467-9. PubMed ID: 19762961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
